---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-051891"
form_type: "8-K"
ticker: "JSPR"
cik: "0001788028"
company_name: "Jasper Therapeutics, Inc."
filed_at: "2024-06-12T23:59:59+00:00"
generated_at: "2026-06-01T04:52:41.068877+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Jasper Therapeutics stockholders approve 2024 equity plans; amended employment agreements for CEO and other executives

## Summary
- Stockholders voted 10.3M for, 95K against to approve 2024 Equity Incentive Plan.
- Stockholders voted 10.4M for, 12K against to approve 2024 Employee Stock Purchase Plan.
- CEO Martell's annual salary remains $727,272; target bonus 50% of base; severance 18 months base plus COBRA.
- CFO Cross salary $476,100; COO Mahal $481,301; CMO Tucker $514,500; each target bonus 45% of base.
- Company terminated prior severance plan in favor of individual employment agreements.

## SEC filing metadata
- accession: 0001213900-24-051891
- form_type: 8-K
- ticker: JSPR
- cik: 0001788028
- company_name: Jasper Therapeutics, Inc.
- filed_at: 2024-06-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1788028/000121390024051891/0001213900-24-051891-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1788028/000121390024051891/ea0207631-8k_jasper.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-051891
- JSON: https://secwatch.observer/filing/0001213900-24-051891.json
- Plain text: https://secwatch.observer/filing/0001213900-24-051891.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.